Goldman Sachs’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,043
| Closed | -$227K | – | 4914 |
|
|
2024
Q2 | $227K | Sell |
8,043
-3,104
| -28% | -$87.4K | ﹤0.01% | 4312 |
|
|
2024
Q1 | $3.34M | Buy |
11,147
+1,953
| +21% | +$586K | ﹤0.01% | 2859 |
|
|
2023
Q4 | $2.17M | Buy |
9,194
+1,249
| +16% | +$295K | ﹤0.01% | 3149 |
|
|
2023
Q3 | $1.19M | Buy |
7,945
+108
| +1% | +$16.2K | ﹤0.01% | 3426 |
|
|
2023
Q2 | $1.36M | Sell |
7,837
-1,182
| -13% | -$206K | ﹤0.01% | 3430 |
|
|
2023
Q1 | $1.14M | Buy |
9,019
+8,342
| +1,232% | +$1.05M | ﹤0.01% | 3578 |
|
|
2022
Q4 | $205K | Buy |
+677
| New | +$205K | ﹤0.01% | 4491 |
|
|
2022
Q1 | – | Sell |
-385
| Closed | -$55K | – | 5803 |
|
|
2021
Q4 | $55K | Buy |
385
+121
| +46% | +$17.3K | ﹤0.01% | 5335 |
|
|
2021
Q3 | $58K | Sell |
264
-970
| -79% | -$213K | ﹤0.01% | 5156 |
|
|
2021
Q2 | $286K | Buy |
1,234
+885
| +254% | +$205K | ﹤0.01% | 4729 |
|
|
2021
Q1 | $105K | Sell |
349
-156
| -31% | -$46.9K | ﹤0.01% | 5025 |
|
|
2020
Q4 | $190K | Sell |
505
-370
| -42% | -$139K | ﹤0.01% | 4286 |
|
|
2020
Q3 | $269K | Sell |
875
-119
| -12% | -$36.6K | ﹤0.01% | 3948 |
|
|
2020
Q2 | $373K | Buy |
994
+34
| +4% | +$12.8K | ﹤0.01% | 3730 |
|
|
2020
Q1 | $219K | Buy |
960
+173
| +22% | +$39.5K | ﹤0.01% | 3904 |
|
|
2019
Q4 | $416K | Sell |
787
-402
| -34% | -$212K | ﹤0.01% | 3737 |
|
|
2019
Q3 | $512K | Buy |
1,189
+634
| +114% | +$273K | ﹤0.01% | 3586 |
|
|
2019
Q2 | $662K | Buy |
555
+100
| +22% | +$119K | ﹤0.01% | 3405 |
|
|
2019
Q1 | $567K | Buy |
455
+45
| +11% | +$56.1K | ﹤0.01% | 3512 |
|
|
2018
Q4 | $388K | Sell |
410
-347
| -46% | -$328K | ﹤0.01% | 3507 |
|
|
2018
Q3 | $1.09M | Buy |
757
+540
| +249% | +$778K | ﹤0.01% | 3161 |
|
|
2018
Q2 | $351K | Sell |
217
-2,059
| -90% | -$3.33M | ﹤0.01% | 3664 |
|
|
2018
Q1 | $3.69M | Buy |
2,276
+1,144
| +101% | +$1.86M | ﹤0.01% | 2513 |
|
|
2017
Q4 | $1.9M | Buy |
+1,132
| New | +$1.9M | ﹤0.01% | 2867 |
|
|
2017
Q3 | – | Sell |
-864
| Closed | -$965K | – | 4322 |
|
|
2017
Q2 | $965K | Buy |
+864
| New | +$965K | ﹤0.01% | 3168 |
|
|
2016
Q3 | – | Sell |
-879
| Closed | -$639K | – | 4581 |
|
|
2016
Q2 | $639K | Buy |
879
+606
| +222% | +$441K | ﹤0.01% | 3185 |
|
|
2016
Q1 | $163K | Sell |
273
-285
| -51% | -$170K | ﹤0.01% | 3866 |
|
|
2015
Q4 | $319K | Buy |
558
+15
| +3% | +$8.58K | ﹤0.01% | 3482 |
|
|
2015
Q3 | $304K | Sell |
543
-198
| -27% | -$111K | ﹤0.01% | 3590 |
|
|
2015
Q2 | $589K | Buy |
741
+1
| +0.1% | +$795 | ﹤0.01% | 3228 |
|
|
2015
Q1 | $616K | Sell |
740
-161
| -18% | -$134K | ﹤0.01% | 3185 |
|
|
2014
Q4 | $649K | Sell |
901
-55
| -6% | -$39.6K | ﹤0.01% | 3202 |
|
|
2014
Q3 | $663K | Sell |
956
-51
| -5% | -$35.4K | ﹤0.01% | 3158 |
|
|
2014
Q2 | $849K | Sell |
1,007
-67
| -6% | -$56.5K | ﹤0.01% | 3051 |
|
|
2014
Q1 | $1.75M | Buy |
+1,074
| New | +$1.75M | ﹤0.01% | 2630 |
|